Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome | 2 | 2023 | 125 | 1.040 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2024 | 2 | 0.950 |
Why?
|
| Chromosomes | 1 | 2023 | 37 | 0.920 |
Why?
|
| Mucin-1 | 1 | 2021 | 9 | 0.780 |
Why?
|
| Cyperaceae | 1 | 2020 | 2 | 0.740 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2020 | 62 | 0.710 |
Why?
|
| Ducks | 3 | 2023 | 8 | 0.640 |
Why?
|
| Glycosylation | 2 | 2024 | 100 | 0.420 |
Why?
|
| Protein Isoforms | 2 | 2024 | 130 | 0.410 |
Why?
|
| Genomics | 3 | 2023 | 223 | 0.280 |
Why?
|
| North America | 2 | 2023 | 67 | 0.270 |
Why?
|
| Chromatiaceae | 1 | 2024 | 1 | 0.250 |
Why?
|
| Autotrophic Processes | 1 | 2024 | 1 | 0.250 |
Why?
|
| Sulfur | 1 | 2024 | 18 | 0.240 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2022 | 86 | 0.240 |
Why?
|
| Sulfides | 1 | 2024 | 62 | 0.240 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2023 | 29 | 0.230 |
Why?
|
| Leukemia | 1 | 2023 | 56 | 0.220 |
Why?
|
| Interleukin-2 | 1 | 2023 | 89 | 0.210 |
Why?
|
| Humans | 13 | 2024 | 37093 | 0.210 |
Why?
|
| Iron | 1 | 2024 | 225 | 0.210 |
Why?
|
| Pyrazoles | 1 | 2022 | 85 | 0.200 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 39 | 0.190 |
Why?
|
| Peptides | 1 | 2024 | 320 | 0.190 |
Why?
|
| Receptors, CCR5 | 2 | 2018 | 61 | 0.190 |
Why?
|
| Sequence Analysis, Protein | 1 | 2020 | 50 | 0.190 |
Why?
|
| Extreme Heat | 1 | 2020 | 3 | 0.190 |
Why?
|
| Arctic Regions | 1 | 2020 | 17 | 0.190 |
Why?
|
| Escherichia coli | 1 | 2023 | 453 | 0.180 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2021 | 132 | 0.180 |
Why?
|
| Alaska | 1 | 2020 | 53 | 0.180 |
Why?
|
| HIV-1 | 2 | 2018 | 706 | 0.180 |
Why?
|
| Gene Expression Profiling | 2 | 2022 | 626 | 0.180 |
Why?
|
| Animals, Wild | 1 | 2020 | 18 | 0.180 |
Why?
|
| Flavivirus Infections | 1 | 2019 | 4 | 0.170 |
Why?
|
| Flavivirus | 1 | 2019 | 15 | 0.170 |
Why?
|
| Temperature | 1 | 2020 | 286 | 0.170 |
Why?
|
| HIV Long-Term Survivors | 1 | 2018 | 7 | 0.170 |
Why?
|
| Virus Internalization | 1 | 2018 | 28 | 0.160 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 186 | 0.150 |
Why?
|
| Algorithms | 1 | 2020 | 465 | 0.150 |
Why?
|
| Nuclear Proteins | 1 | 2019 | 307 | 0.150 |
Why?
|
| Virus Replication | 1 | 2019 | 278 | 0.150 |
Why?
|
| Signal Transduction | 2 | 2023 | 1908 | 0.140 |
Why?
|
| Animals | 4 | 2023 | 15081 | 0.110 |
Why?
|
| Bystander Effect | 1 | 2012 | 11 | 0.110 |
Why?
|
| Hybridization, Genetic | 2 | 2023 | 14 | 0.100 |
Why?
|
| HIV Infections | 2 | 2018 | 2303 | 0.100 |
Why?
|
| Phosphorylation | 2 | 2023 | 928 | 0.090 |
Why?
|
| HIV Envelope Protein gp41 | 2 | 2018 | 7 | 0.070 |
Why?
|
| Apoptosis | 1 | 2012 | 1398 | 0.060 |
Why?
|
| Photosynthesis | 1 | 2024 | 29 | 0.060 |
Why?
|
| Ribosome Subunits, Large, Bacterial | 1 | 2023 | 1 | 0.060 |
Why?
|
| Electrons | 1 | 2024 | 68 | 0.060 |
Why?
|
| RNA, Ribosomal, 23S | 1 | 2023 | 5 | 0.060 |
Why?
|
| Pseudouridine | 1 | 2023 | 6 | 0.060 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2023 | 13 | 0.060 |
Why?
|
| Ribosomes | 1 | 2023 | 32 | 0.060 |
Why?
|
| Breeding | 1 | 2023 | 21 | 0.060 |
Why?
|
| RNA, Bacterial | 1 | 2023 | 33 | 0.060 |
Why?
|
| Europe | 1 | 2023 | 101 | 0.060 |
Why?
|
| Janus Kinase 1 | 1 | 2023 | 18 | 0.060 |
Why?
|
| Janus Kinase 3 | 1 | 2023 | 35 | 0.060 |
Why?
|
| Janus Kinases | 1 | 2023 | 21 | 0.060 |
Why?
|
| Escherichia coli Proteins | 1 | 2023 | 126 | 0.050 |
Why?
|
| Phosphatidylserines | 1 | 2022 | 21 | 0.050 |
Why?
|
| Molecular Conformation | 1 | 2022 | 152 | 0.050 |
Why?
|
| Exocytosis | 1 | 2022 | 47 | 0.050 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2022 | 78 | 0.050 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2022 | 84 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2022 | 113 | 0.050 |
Why?
|
| Caspases | 1 | 2022 | 147 | 0.050 |
Why?
|
| Tubulin | 1 | 2022 | 88 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2022 | 389 | 0.050 |
Why?
|
| Ligands | 1 | 2022 | 349 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2022 | 251 | 0.050 |
Why?
|
| Cell Death | 1 | 2022 | 267 | 0.050 |
Why?
|
| Databases, Protein | 1 | 2020 | 48 | 0.050 |
Why?
|
| Microtubules | 1 | 2022 | 120 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2022 | 444 | 0.050 |
Why?
|
| Health Personnel | 1 | 2023 | 228 | 0.050 |
Why?
|
| Mexico | 1 | 2021 | 240 | 0.050 |
Why?
|
| Binding Sites | 1 | 2022 | 651 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2022 | 326 | 0.050 |
Why?
|
| Gene Flow | 1 | 2020 | 14 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2022 | 213 | 0.040 |
Why?
|
| Hospitalization | 1 | 2023 | 388 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2024 | 540 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2019 | 18 | 0.040 |
Why?
|
| RNA Viruses | 1 | 2019 | 22 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 239 | 0.040 |
Why?
|
| RNA, Transfer | 1 | 2019 | 28 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 461 | 0.040 |
Why?
|
| Protein Binding | 1 | 2022 | 972 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2019 | 188 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 173 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2019 | 109 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2022 | 808 | 0.040 |
Why?
|
| Cell Movement | 1 | 2022 | 571 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 1180 | 0.040 |
Why?
|
| Kinetics | 1 | 2019 | 708 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2018 | 191 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2018 | 474 | 0.040 |
Why?
|
| Mutation | 1 | 2021 | 1095 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2022 | 807 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2022 | 1198 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 674 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 1354 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2022 | 2231 | 0.030 |
Why?
|
| Membrane Fusion | 1 | 2012 | 11 | 0.030 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 19 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2012 | 69 | 0.030 |
Why?
|
| Autophagy | 1 | 2012 | 116 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 601 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 1371 | 0.020 |
Why?
|
| Female | 1 | 2022 | 20969 | 0.010 |
Why?
|
| Male | 1 | 2018 | 20025 | 0.010 |
Why?
|